It is also notable that we identified over 10 cancer-related genes (including PHGDH, CCND1, IGFBP-2, XAGE1B/E, CYP4F22, RBM11, ORAOV1, MDK, UGT3A5, SSX5, FBL, NKX2) potentially overexpressed in EFT tumors. This evidence concerns the gene LTO1 and cancer.